SP
Healthcare & Life Sciences
SERB Specialty Pharmaceuticals
France
SERB Specialty Pharmaceuticals is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About SERB Specialty Pharmaceuticals
SERB Specialty Pharmaceuticals is a company headquartered in France. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
SERB Specialty Pharmaceuticals develops, acquires, and markets prescription medicines targeting rare and life-threatening diseases. It operates directly in Europe, the Middle East, and Australia, and distributes its products globally through a network covering over 80 countries.
Explore SERB Specialty Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.